Myeloid Leukemias Active Not Recruiting Phase 1 Trials for Sabatolimab (DB16322)

Back to Myeloid Leukemias

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

Indication	Status	Phase
DBCOND0042450 (Myeloid Leukemias)	Active Not Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03066648	Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS	Treatment	Azacitidine (DB00928) Decitabine (DB01262) Sabatolimab (DB16322) Spartalizumab (DB14892)